XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Condensed Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash flows from operating activities:    
Net income (loss) $ (153,316) $ 23,150
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation 8,090 8,741
Amortization of debt discount 0 5,031
Amortization of deferred debt issuance costs 1,916 2,116
Amortization 26,065 27,316
Stock-based compensation 10,218 7,676
Deferred income taxes 70,402 (1,781)
Loss on early extinguishment of debt 3,426 0
Loss on convertible notes conversion premium 103,125 0
Loss on convertible notes hedge transactions settlement 5,460 0
Increase (decrease) in cash flows from changes in assets and liabilities:    
Accounts receivable (17,779) 7,780
Inventories (35,549) (16,693)
Accounts payable 13,724 2,547
Accrued compensation and benefits (12,260) (769)
Other assets (11,388) (12,289)
Other liabilities 6,936 3,798
Net cash provided by operating activities 19,070 56,623
Cash flows from investing activities:    
Purchases of property, plant and equipment (9,398) (6,103)
Payments related to business acquisition, net of cash acquired (142,555) 0
Net cash used in investing activities (151,953) (6,103)
Cash flows from financing activities:    
Payments on term loan (92,981) (8,281)
Payments on revolving line of credit (312,000) (161,000)
Proceeds from revolving line of credit 172,000 139,000
Payments to redeem convertible notes (275,000) 0
Proceeds from issuance of convertible notes 800,000 0
Payments related to debt issuance costs (21,187) 0
Dividends paid on common stock (11,773) (11,588)
Purchases of convertible notes hedge transactions (187,600) 0
Proceeds from issuance of warrants 72,000 0
Proceeds from settlement of convertible notes hedge transactions 86,228 0
Payment for settlement of warrants (69,534) 0
Other, net 6,457 10,902
Net cash provided by (used in) financing activities 166,610 (30,967)
Effect of exchange rate changes on cash and cash equivalents (1,422) (521)
Net increase in cash and cash equivalents 32,305 19,032
Cash and cash equivalents at beginning of period 20,847 27,356
Cash and cash equivalents at end of period 53,152 46,388
Non-cash investing and financing activities:    
Contingent consideration 69,402 0
Dividends payable $ 6,092 $ 5,830